πŸ‡ΊπŸ‡Έ FDA
Patent

US 10968442

Chimeric clotting factors

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 10968442 (Chimeric clotting factors) held by BIOVERATIV THERAPEUTICS INC. expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOVERATIV THERAPEUTICS INC.
Grant date
Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/505, A61K38/00, A61P, A61P7/04